Insect resistance management with combinations of Cry1Be and Cry1F proteins

US9556453B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9556453-B2
Application numberUS-201013516629-A
CountryUS
Kind codeB2
Filing dateDec 16, 2010
Priority dateDec 16, 2009
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The subject invention relates in part to stacking Cry1Be toxins along with Cry1Fa toxins to prevent insects from developing resistance towards either toxin by itself. As discussed in more detail herein, the subject pair of proteins is a particularly advantageous combination, as no other pair of proteins is known to provide high levels of control and non-cross-resistant activity against both Spodoptera frugiperda (FAW) and Ostrinia nubilalis (ECB) insects. This dual, non-cross-resistant activity is also advantageous because it can reduce the number of proteins/genes needed to target these insects with multiple, non-cross-resistant proteins. This can reduce or eliminate the need for refuge acreage. Accordingly, the subject invention also relates generally to using four genes to provide three proteins for non-cross-resistant control of a first insect, and three proteins for non-cross-resistant control of a second insect. In preferred embodiments, the targeted insects are FAW and ECB.

First claim

Opening claim text (preview).

We claim: 1. A transgenic plant comprising DNA encoding a Cry1Be insecticidal protein and DNA encoding a Cry1Fa insecticidal protein, wherein said Cry1Fa insecticidal protein is at least 95% identical with SEQ ID NO:1, and said Cry1Be insecticidal protein is at least 95% identical with SEQ ID NO:2, wherein said transgenic plant expresses an effective amount of said Cry1Fa insecticidal protein and said Cry1Be insecticidal protein to prevent development of Cry-resistant lepidopteran pests, and wherein said Cry1Fa insecticidal protein and said Cry1Be insecticidal protein do not share a receptor binding site in European corn borer (ECB) gut and do not share a receptor binding site in fall armyworm (FAW) gut. 2. A seed of the plant of claim 1 comprising DNA encoding said Cry1Be insecticidal protein and DNA encoding said Cry1Fa insecticidal protein. 3. A plurality of plants comprising non-Bt refuge plants and a plurality of transgenic plants of claim 1 , wherein said refuge plants comprise less than 40% of all crop plants in said plurality of plants. 4. The plurality of plants of claim 3 , wherein said refuge plants are in blocks or strips. 5. A mixture of seeds comprising refuge seeds from non-Bt refuge plants, and a plurality of seeds of claim 2 , wherein said refuge seeds comprise less than 40% of all the seeds in the mixture. 6. A method of managing development of resistance to a Cry toxin by an insect, said method comprising planting seeds to produce the plurality of plants of claim 3 . 7. A composition for controlling Cry1Fa-resistant lepidopteran pests, said composition comprising cells that express effective amounts of both a Cry1Fa core toxin-containing protein and a Cry1Be core toxin-containing protein, wherein said Cry1Fa core-toxin containing protein and said Cry1Be core toxin-containing insecticidal protein do not share a receptor binding site in ECB gut and do not share a receptor binding site in FAW gut. 8. The composition of claim 7 comprising a host transformed to express both said Cry1Fa protein and said Cry1Be protein, wherein said host is a microorganism or a plant cell. 9. A method of controlling Cry1Fa-resistant lepidopteran pests, said method comprising presenting to said pests or to the environment of said pests an effective amount of the composition of claim 7 , wherein said lepidopteran pests are selected from the group consisting of European corn borer and fall armyworm. 10. A transgenic plant that produces four insecticidal proteins derived from Bacillus thuringiensis , wherein three of said proteins provide non-cross-resistant activity against a first insect, and three of said proteins provide non-cross-resistant activity against a second insect, wherein said plant comprises DNA encoding a Cry1Fa insecticidal protein and DNA encoding a Cry1Be insecticidal protein, wherein said first insect is European corn borer and said second insect is fall armyworm, and wherein said Cry1Fa insecticidal protein and said Cry1Be insecticidal protein do not share a receptor binding site in ECB gut and do not share a receptor binding site in FAW gut. 11. The transgenic plant of claim 1 , wherein the plant produces a third protein selected from the group consisting of Cry1Ab, Cry2Aa, and Cry1I proteins. 12. The transgenic plant of claim 1 , wherein the plant produces a third protein selected from the group consisting of Vip3A, Cry1C, Cry1D, and Cry1E proteins. 13. The transgenic plant of claim 11 , wherein the plant produces a fourth protein selected from the group consisting of Vip3A, Cry1C, Cry1D, and Cry1E proteins. 14. A method of managing development of resistance to a Cry1Fa toxin by European corn borer and fall armyworm, said method comprising planting seeds to produce the transgenic plant of claim 10 . 15. A plurality of plants comprising non-Bt refuge plants and a plurality of the transgenic plants of claim 10 , wherein said refuge plants comprise less than about 20% of all crop plants in said plurality of plants. 16. A method of managing development of resistance to a Cry1Fa toxin by European corn borer and fall armyworm, said method comprising planting seeds to produce the plurality of plants of claim 15 . 17. A mixture of seeds comprising refuge seeds from non-Bt refuge plants, and a plurality of transgenic seeds from the plant of claim 10 , wherein said refuge seeds comprise less than 10% of all the seeds in the mixture. 18. A plant cell of the plant of claim 1 , wherein said plant cell comprises said DNA encoding said Cry1Fa insecticidal protein and said DNA encoding said Cry1Be insecticidal protein, wherein said Cry1Fa insecticidal protein is at least 99% identical with SEQ ID NO: 1, and said Cry1Be insecticidal protein is at least 99% identical with SEQ ID NO: 2. 19. The plant of claim 1 , wherein said Cry1Fa insecticidal protein comprises SEQ ID NO:1, and said Cry1Be insecticidal protein comprises SEQ ID NO:2. 20. A method of controlling a Cry resistant insect selected from the group consisting of a European corn borer and a fall armyworm, said method comprising contacting said insect with a Cry1Be insecticidal protein and a Cry1Fa insecticidal protein, wherein said Cry1Fa insecticidal protein and said Cry1Be insecticidal protein do not share a receptor binding site in ECB gut and do not share a receptor binding site in FAW gut. 21. A plant cell of the plant of claim 10 , wherein said Cry1Fa insecticidal protein is at least 99% identical with SEQ ID NO:1, and said Cry1Be insecticidal protein is at least 99% identical with SEQ ID NO:2. 22. The plant of claim 10 , wherein said Cry1Fa insecticidal protein comprises SEQ ID NO:1, and said Cry1Be insecticidal protein comprises SEQ ID NO:2.

Assignees

Inventors

Classifications

  • for insect resistance · CPC title

  • Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof (containing compounds of determined constitution A01N27/00 - A01N59/00) · CPC title

  • Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48 · CPC title

  • Human Necessities · mapped topic

  • Isolated enzymes; Isolated proteins (peptides A01N37/46) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9556453B2 cover?
The subject invention relates in part to stacking Cry1Be toxins along with Cry1Fa toxins to prevent insects from developing resistance towards either toxin by itself. As discussed in more detail herein, the subject pair of proteins is a particularly advantageous combination, as no other pair of proteins is known to provide high levels of control and non-cross-resistant activity against both Sp…
Who is the assignee on this patent?
Meade Thomas, Narva Kenneth, Storer Nicholas P, and 4 more
What technology area does this patent fall under?
Primary CPC classification C12N15/8286. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).